LB Pharmaceuticals

tenant

drug

PACE-Life

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

BEHAVIORAL

Pre-approval / investigational in the US

Developed by University of North Carolina, Chapel Hill

1 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

BEHAVIORAL

Indications

Investigational (via trials)

Schizophrenia Brief Psychotic Disorder Schizophreniform Disorders Schizophrenia Unspecified Schizophrenia Spectrum and Other Psychotic Disorder Psychotic Disorders Motor Activity Schizoaffective Disorder

Trials

1

Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial

NCT04173572—Completed

KOLs & investigators

1

David L. Penn, PhDKOL score 5

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

University of North Carolina, Chapel Hill

company

trial

Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial

NA

trial

indication

indication

Brief Psychotic Disorder

indication

Schizophreniform Disorders

indication

indication

KOL

David L. Penn, PhD

KOL score 5

person